Results 71 to 80 of about 4,637,209 (304)

Characterizing epithelial‐mesenchymal transition‐linked heterogeneity in breast cancer circulating tumor cells at a single‐cell level

open access: yesMolecular Oncology, EarlyView.
In over 50% of non‐metastatic breast cancer patients, circulating tumor cells (CTCs) along the whole epithelial‐mesenchymal transition spectrum are detected. Total CTC number and individual phenotypes relate to aggressive disease characteristics, including lymph node involvement and higher tumor proliferation. At the single‐cell level, mesenchymal CTCs
Justyna Topa   +14 more
wiley   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

open access: yesMolecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero   +11 more
wiley   +1 more source

Screening for lung cancer: A systematic review of overdiagnosis and its implications

open access: yesMolecular Oncology, EarlyView.
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz   +12 more
wiley   +1 more source

Using the IMEDS distributed database for epidemiological studies in type 2 diabetes mellitus. [PDF]

open access: yesBMJ Open Diabetes Res Care, 2022
Huang TY   +15 more
europepmc   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

open access: yesMolecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir   +12 more
wiley   +1 more source

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

open access: yesMolecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto   +13 more
wiley   +1 more source

Record matching method based on local CON model in distributed database

open access: yesTongxin xuebao, 2011
For existing record matching methods needed much artificial participation of experts or depend on heuristic rules heavily,and they could not handle the problem of large-scale data,A record matching method based on the local CON model was proposed.The ...
LI Jiao1   +3 more
doaj  

Semi-Distributed Vacuuming Model on Temporal Database (SDVMT) [PDF]

open access: yesDatabase Systems Journal, 2012
Temporal database is one of the most common types of databases. Portfolio management, accounting, storage, treatment management systems, aerology systems and scheduling are applications which their data have time references.
Mohammad Shabanali FAMI   +3 more
doaj  

Building Infrastructure Distributed Database in CV. Cipta Solusi Sejahtera

open access: yesJurnal Sisfokom, 2016
Sistem basis data terdistribusi merupakan suatu bentuk arsitektur sistem dimana komputer-komputer  yang berdiri secara otonom dapat saling berkomunikasi dan berbagi resource tanpa memperdulikan dimana komputer itu berada dan platform yang digunakan ...
Benny Wijaya, Boy Valentino
doaj   +1 more source

Home - About - Disclaimer - Privacy